| Product Name | MF | CAS | Details |
|---|
| Bleximenib oxalate | 2866179-95-3 | Details |
| FX-06 | C133H216N44O38 | 88650-17-3 | Details |
| MC-Val-Cit-PAB-NH-C2-NH-Boc | C36H54N8O10 | 1616727-22-0 | Details |
| PB038 | C98H149FN12O36 | 2851058-71-2 | Details |
| Enerisant HCl | C22H30N4O3.ClH | 1152749-07-9 | Details |
| Bio-AMS | C20H29N9O7S2 | 1393881-52-1 | Details |
| FK-330 dihydrate | C29H30ClF3N6O5 | 682813-92-9 | Details |
| Trapencaine | C22H34N2O3 | 76629-91-9 | Details |
| MC-Val-Cit-PAB-Exatecan | C53H60FN9O12 | 2504068-28-2 | Details |
| CVN636 | C19H20FNO4S | 2226732-62-1 | Details |
| Patritumab deruxtecan | 2227102-46-5 | Details |
| URAT1 inhibitor 8 | 1632005-33-4 | Details |
| Skp2 inhibitor 2 | 2760612-77-7 | Details |
| Compound STL565749 | C19H17N3O | 879771-67-2 | Details |
| ELOVL6-IN-3 | C27H24F3N3O3 | 712346-06-0 | Details |
| 3,7-dimethylocta-2,6-dienyl 5,9,13-trimethyltetradeca-4,8,12-enoate | C27H44O2 | 16898-88-7 | Details |
| KRAS inhibitor FB9 | C23H21ClF4N2O5 | 2042365-57-9 | Details |
| INX-SM-56 | C32H36N2O6S | 2734878-18-1 | Details |
| Tallimustine HCl | C32H39Cl3N10O4 | 118438-45-2 | Details |
| (3aR,9aR)-Fluparoxan | 105182-47-6 | Details |
| SNIPER(TACC3)-11 | 2906151-68-4 | Details |
| Pateamine A | C31H45N3O4S | 139220-18-1 | Details |
| MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan | C55H60FN9O13 | 2414393-22-7 | Details |
| BDM91270 | 2892824-11-0 | Details |
| M-COPA | C25H34N2O2 | 861718-91-4 | Details |
| GS-9822 | C36H39ClN4O4S | 2219362-41-9 | Details |
| Ambrein | C30H52O | 473-03-0 | Details |
| PROTAC EZH2 Degrader-1 | C54H67N7O8 | 2641601-67-2 | Details |
| PERK-IN-6 | C23H22N6O | 1337532-14-5 | Details |
| PI5P4Ks-IN-2 | 2766854-03-7 | Details |
| HFY-4A | 2094810-82-7 | Details |
| PCSK9-IN-3 | 2867496-34-0 | Details |
| Lodoxamide ethyl | C15H14ClN3O6 | 53882-13-6 | Details |
| SJ995973 | 2882065-25-8 | Details |
| ERK1/2 inhibitor 9 | 2169302-75-2 | Details |
| AA74-1 | C16H28N4O2 | 1361532-00-4 | Details |
| CeMMEC1 HCl | C19H17ClN2O4 | 2095432-53-2 | Details |
| 5-Fluoromethylornithine dihydrochloride | C6H14ClFN2O2 | 124796-41-4 | Details |
| Anticonvulsant agent 2 | C21H17ClN2 | 75220-84-7 | Details |
| Inbakicept | 2135939-52-3 | Details |
| Verazine | C27H43NO | 14320-81-1 | Details |
| Type II TRK?inhibitor 1 | 2937543-72-9 | Details |
| TMV-IN-2 | 2883408-32-8 | Details |
| Foslevodopa | C9H12NO7P | 97321-87-4 | Details |
| Ac-Lys-Val-Cit-PABC-MMAE | C66H108N12O14 | 1650569-89-3 | Details |
| Fosopamine(HCl) | C9H14NO5P.ClH | 135962-35-5 | Details |
| EGGGG-PEG8-amide-bis(deoxyglucitol) | 2842855-38-1 | Details |
| Laprafylline | C29H36N6O2 | 90749-32-9 | Details |
| HDAC-IN-55 | C17H17N3O3 | 1268674-16-3 | Details |
| Glycopyrronium tosylate | C26H35NO6S | 1624259-25-1 | Details |
| Lanopepden mesylate | C23H38FN7O7S | 1441390-17-5 | Details |
| Berubicin HCl | C34H35NO11. HCl | 293736-67-1 | Details |
| CM-352 | 1542205-83-3 | Details |
| SMS2-IN-2 | C19H13ClFN3O2 | 2241838-28-6 | Details |
| Orniplabin | C51 H68 N2 O10 | 733805-92-0 | Details |
| FEN1-IN-5 | C21H17N3O4S | 824983-93-9 | Details |
| Fluparoxan hydrochloride | C10H11ClFNO2 | 105227-44-9 | Details |
| Burapitant | C31H35Cl2F6N3O3 | 537034-22-3 | Details |
| Naluzotan hydrochloride | C23H39ClN4O3S | 740873-82-9 | Details |
| Ras inhibitor 134 | 2648552-54-7 | Details |
| LEM-14-1189 | 2987501-17-5 | Details |
| Budipine Hydrochloride | C21H28ClN | 63661-61-0 | Details |
| Crobenetine | C25H33NO2 | 221019-25-6 | Details |
| VKGILS-NH2 TFA | C30H55F3N8O9 | 2828432-41-1 | Details |
| Niravoline | C22H25N3O3 | 130610-93-4 | Details |
| Canlitinib | C33H31F2N3O7 | 2222730-78-9 | Details |
| Impromidine hydrochloride | C14H24ClN7S | 65573-02-6 | Details |
| Mequitamium | C21H25N2S+ | 101396-46-7 | Details |
| Ot-730 | C25H36N2O8 | 870809-51-1 | Details |
| ER-34122 | C27H26ClN3O5 | 179325-62-3 | Details |
| MMV009085 | C22H22N2O6 | 298217-59-1 | Details |
| Mal-PEG2-Val-Cit-PABA | C27H38N6O9 | 1662687-83-3 | Details |
| VEGFR-3-IN-1 | C29H29ClF3N7OS | 2756668-73-0 | Details |
| KT-531 | C17H14F4N2O4S | 2490284-18-7 | Details |
| SLC26A3-IN-1 | C23H18O4 | 307552-53-0 | Details |
| EPZ032597 | C20H23N7O | 1887193-58-9 | Details |
| Tirilazad | C38H52N6O2 | 110101-66-1 | Details |
| Cisd2 agonist 1 | 2916371-54-3 | Details |
| Glycolithocholic acid 3-sulfate | C26H43NO7S | 15324-64-8 | Details |
| (6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid | C18H19NO2 | 89667-39-0 | Details |
| NLRP3-IN-18 | C19H18ClN3O | 2769040-06-2 | Details |
| TC-2216 | C12H17N3 | 646055-67-6 | Details |
| YM281 | C56H71N7O9S | 2230914-84-6 | Details |
| JAK-IN-25 | C19H17N5O4 | 2127110-22-7 | Details |
| TMV-IN-3 | 2883408-35-1 | Details |
| YM-58790 | C27H31N3O2 | 168830-70-4 | Details |
| NSC194598 | C20H19N3O | 5358-76-9 | Details |
| GlcNAcstatin | C20H27N3O4 | 922163-64-2 | Details |
| Naltrindole | C26H26N2O3 | 111555-53-4 | Details |
| Metronidazole hydrochloride | C6H9N3O3.ClH | 69198-10-3 | Details |
| UniPR505 | 2938227-14-4 | Details |
| KRAS G12C inhibitor 56 | C32H39N7O4S | 2749963-77-5 | Details |
| Ainsliadimer A | C30H34O7 | 1039431-94-1 | Details |
| Bulgecin A | C16H29N3O14S2 | 92953-54-3 | Details |
| N′-(2-Chloroethyl)-N-(4-methylcyclohexyl)-N-nitrosourea | C10H18ClN3O2 | 75219-93-1 | Details |
| 7-Aminomethyl-10-methyl-11-fluoro camptothecin | C22H20FN3O4 | 2378616-23-8 | Details |
| KRAS G12C inhibitor 1R | C31H36ClFN6O2 | 2927439-07-2 | Details |
| Serazapine | C22H23N3O2 | 115313-22-9 | Details |
| Bi-Mc-VC-PAB-MMAE | C71H104N12O18 | 1620837-70-8 | Details |
| EPZ033294 | C20H22ClN7O | 1887195-17-6 | Details |
| Product Total： Product Page： | ||||
| 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||